• Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Recro Pharma Inc

+ Add to Watchlist

REPH:US

2.8500 USD 0.00000.00%

As of 17:10:00 ET on 12/24/2014.

Snapshot for Recro Pharma Inc (REPH)

Open: 2.8000 Day's Range: 2.7900 - 2.8900 Volume: 8,100
Previous Close: 2.8500 52wk Range: 2.3600 - 9.8800 1-Yr Rtn: -

Stock Chart for REPH

No chart data available.
  • REPH:US 2.8500
  • 1D
  • 1M
  • 1Y
2.8500
Interactive REPH Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for REPH

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -3.0830
Est. PEG Ratio -
Market Cap (M USD) 21.97
Shares Outstanding (M) 7.71
30 Day Average Volume 42,899
Price/Book (mrq) 0.9892
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/10/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for REPH

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for REPH

Recro Pharma, Inc. is a specialty pharmaceutical company. The Company develops non-opioid therapeutics for the treatment of pain in the post-operative setting. Recro Pharma offers its products to the medical industry.

Geraldine A Henwood "Gerri"President/CEOCharles GarnerCFO/Chief Bus Ofcr/Treasurer
Donna M NicholsChief Acctg Officer/ControllerRandall J MackSenior VP:Dev/Secretary
More Company Profile & Key Executives for REPH

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil